• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53在炎症性肿瘤微环境调节及肿瘤抑制中的作用

Role of p53 in the Regulation of the Inflammatory Tumor Microenvironment and Tumor Suppression.

作者信息

Uehara Ikuno, Tanaka Nobuyuki

机构信息

Department of Molecular Oncology, Institute for Advanced Medical Sciences, Nippon Medical School, 1-396 Kosugi-cho, Nakahara-ku, Kawasaki 211-8533, Japan.

出版信息

Cancers (Basel). 2018 Jun 27;10(7):219. doi: 10.3390/cancers10070219.

DOI:10.3390/cancers10070219
PMID:29954119
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6071291/
Abstract

p53 has functional roles in tumor suppression as a guardian of the genome, surveillant of oncogenic cell transformation, and as recently demonstrated, a regulator of intracellular metabolism. Accumulating evidence has shown that the tumor microenvironment, accompanied by inflammation and tissue remodeling, is important for cancer proliferation, metastasis, and maintenance of cancer stem cells (CSCs) that self-renew and generate the diverse cells comprising the tumor. Furthermore, p53 has been demonstrated to inhibit inflammatory responses, and functional loss of p53 causes excessive inflammatory reactions. Moreover, the generation and maintenance of CSCs are supported by the inflammatory tumor microenvironment. Considering that the functions of p53 inhibit reprogramming of somatic cells to stem cells, p53 may have a major role in the inflammatory microenvironment as a tumor suppressor. Here, we review our current understanding of the mechanisms underlying the roles of p53 in regulation of the inflammatory microenvironment, tumor microenvironment, and tumor suppression.

摘要

p53作为基因组的守护者、致癌细胞转化的监测者以及最近所证实的细胞内代谢的调节者,在肿瘤抑制中发挥着功能性作用。越来越多的证据表明,伴有炎症和组织重塑的肿瘤微环境对于癌症增殖、转移以及自我更新并产生构成肿瘤的多种细胞的癌症干细胞(CSCs)的维持非常重要。此外,p53已被证明可抑制炎症反应,p53的功能丧失会导致过度的炎症反应。而且,炎症性肿瘤微环境支持CSCs的产生和维持。鉴于p53的功能可抑制体细胞重编程为干细胞,p53可能在炎症微环境中作为肿瘤抑制因子发挥主要作用。在此,我们综述了目前对p53在调节炎症微环境、肿瘤微环境及肿瘤抑制中所起作用的潜在机制的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57c3/6071291/e6f950d8922a/cancers-10-00219-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57c3/6071291/e6f950d8922a/cancers-10-00219-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57c3/6071291/e6f950d8922a/cancers-10-00219-g001.jpg

相似文献

1
Role of p53 in the Regulation of the Inflammatory Tumor Microenvironment and Tumor Suppression.p53在炎症性肿瘤微环境调节及肿瘤抑制中的作用
Cancers (Basel). 2018 Jun 27;10(7):219. doi: 10.3390/cancers10070219.
2
Nuclear factor-kappaB-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53.在表达突变型p53的肺癌细胞系中,转移抑制因子KAI1/CD82基因的核因子-κB依赖性表达。
Cancer Res. 2001 Jan 15;61(2):673-8.
3
Inflammation and p53: A Tale of Two Stresses.炎症与p53:两种应激的故事
Genes Cancer. 2011 Apr;2(4):503-16. doi: 10.1177/1947601911409747.
4
Triptolide-Assisted Phosphorylation of p53 Suppresses Inflammation-Induced NF-κB Survival Pathways in Cancer Cells.雷公藤甲素辅助的p53磷酸化抑制癌细胞中炎症诱导的NF-κB生存通路。
Mol Cell Biol. 2017 Jul 14;37(15). doi: 10.1128/MCB.00149-17. Print 2017 Aug 1.
5
Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness.p53的新兴非经典功能与调控:p53与干性
Int J Mol Sci. 2016 Nov 26;17(12):1982. doi: 10.3390/ijms17121982.
6
New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy.靶向肿瘤微环境中肿瘤抑制因子 p53 通路以增强免疫疗法疗效的新视角。
J Immunother Cancer. 2015 Mar 24;3:9. doi: 10.1186/s40425-015-0053-5. eCollection 2015.
7
p53 and stem cells: new developments and new concerns.p53 与干细胞:新进展与新问题。
Trends Cell Biol. 2010 Mar;20(3):170-5. doi: 10.1016/j.tcb.2009.12.004. Epub 2010 Jan 12.
8
p53 Signaling on Microenvironment and Its Contribution to Tissue Chemoresistance.p53信号传导对微环境的影响及其对组织化学抗性的作用。
Membranes (Basel). 2022 Feb 9;12(2):202. doi: 10.3390/membranes12020202.
9
IKK/nuclear factor-kappaB and oncogenesis: roles in tumor-initiating cells and in the tumor microenvironment.IKK/核因子-κB与肿瘤发生:在肿瘤起始细胞及肿瘤微环境中的作用
Adv Cancer Res. 2014;121:125-145. doi: 10.1016/B978-0-12-800249-0.00003-2.
10
The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.Pinx1基因通过调控Trfs和Mad1/C-Myc/p53信号通路下调端粒酶并抑制从鼻咽癌细胞系分离出的CD133+癌干细胞的增殖。
Cell Physiol Biochem. 2018;49(1):282-294. doi: 10.1159/000492878. Epub 2018 Aug 23.

引用本文的文献

1
The Multifaceted Role of p53 in Cancer Molecular Biology: Insights for Precision Diagnosis and Therapeutic Breakthroughs.p53在癌症分子生物学中的多面角色:精准诊断与治疗突破的见解
Biomolecules. 2025 Jul 27;15(8):1088. doi: 10.3390/biom15081088.
2
Molecular Mechanisms in the Carcinogenesis of Oral Squamous Cell Carcinoma: A Literature Review.口腔鳞状细胞癌发生的分子机制:文献综述
Biomolecules. 2025 Apr 25;15(5):621. doi: 10.3390/biom15050621.
3
Unlocking the Microbial Symphony: The Interplay of Human Microbiota in Cancer Immunotherapy Response.

本文引用的文献

1
Targeting the microenvironment in solid tumors.靶向实体瘤的微环境。
Cancer Treat Rev. 2018 Apr;65:22-32. doi: 10.1016/j.ctrv.2018.02.004. Epub 2018 Feb 22.
2
NF-κB, inflammation, immunity and cancer: coming of age.NF-κB、炎症、免疫与癌症:崭露头角。
Nat Rev Immunol. 2018 May;18(5):309-324. doi: 10.1038/nri.2017.142. Epub 2018 Jan 22.
3
Impact of oncogenic pathways on evasion of antitumour immune responses.致癌途径对逃避抗肿瘤免疫反应的影响。
揭开微生物的交响曲:人类微生物群在癌症免疫治疗反应中的相互作用。
Cancers (Basel). 2025 Feb 26;17(5):813. doi: 10.3390/cancers17050813.
4
Germline-Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking ATM to TP53 Synthetic Essentiality.BRCA相关癌症中的种系-体细胞相互作用:将ATM与TP53合成必需性联系起来的独特分子特征和临床结果
Clin Cancer Res. 2025 May 1;31(9):1730-1745. doi: 10.1158/1078-0432.CCR-24-2058.
5
Molecular evidence of the inhibitory potential of melatonin against sodium arsenite toxicity.褪黑素对亚砷酸钠毒性抑制潜力的分子证据。
Heliyon. 2025 Jan 21;11(3):e42113. doi: 10.1016/j.heliyon.2025.e42113. eCollection 2025 Feb 15.
6
Expression of Leukemia Inhibitory Factor (LIF) and p53 on Human Fetal Lung After Chorioamnionitis Suffering.绒毛膜羊膜炎后人类胎儿肺中白血病抑制因子(LIF)和p53的表达
Cureus. 2024 Dec 23;16(12):e76246. doi: 10.7759/cureus.76246. eCollection 2024 Dec.
7
Chronic kidney disease and aging: dissecting the p53/p21 pathway as a therapeutic target.慢性肾脏病与衰老:剖析p53/p21信号通路作为治疗靶点
Biogerontology. 2024 Dec 26;26(1):32. doi: 10.1007/s10522-024-10173-z.
8
DNA Damage and Inflammatory Response of p53 Null H358 Non-Small Cell Lung Cancer Cells to X-Ray Exposure Under Chronic Hypoxia.p53基因缺失的H358非小细胞肺癌细胞在慢性低氧条件下对X射线照射的DNA损伤及炎症反应
Int J Mol Sci. 2024 Nov 23;25(23):12590. doi: 10.3390/ijms252312590.
9
Identification of TPI1 As a potential therapeutic target in pancreatic cancer with dependency of TP53 mutation using multi-omics analysis.利用多组学分析鉴定 TPI1 作为具有 TP53 突变依赖性的胰腺癌潜在治疗靶点。
Cancer Sci. 2024 Nov;115(11):3622-3635. doi: 10.1111/cas.16302. Epub 2024 Sep 11.
10
Targeting Hdm2 and Hdm4 in Anticancer Drug Discovery: Implications for Checkpoint Inhibitor Immunotherapy.靶向抗癌药物发现中的 Hdm2 和 Hdm4:对检查点抑制剂免疫治疗的影响。
Cells. 2024 Jun 29;13(13):1124. doi: 10.3390/cells13131124.
Nat Rev Cancer. 2018 Mar;18(3):139-147. doi: 10.1038/nrc.2017.117. Epub 2018 Jan 12.
4
EMT in cancer.肿瘤中的 EMT。
Nat Rev Cancer. 2018 Feb;18(2):128-134. doi: 10.1038/nrc.2017.118. Epub 2018 Jan 12.
5
Targeting mutant p53 for efficient cancer therapy.针对突变型 p53 进行有效的癌症治疗。
Nat Rev Cancer. 2018 Feb;18(2):89-102. doi: 10.1038/nrc.2017.109. Epub 2017 Dec 15.
6
Mutant p53 shapes the enhancer landscape of cancer cells in response to chronic immune signaling.突变型p53响应慢性免疫信号塑造癌细胞的增强子景观。
Nat Commun. 2017 Sep 29;8(1):754. doi: 10.1038/s41467-017-01117-y.
7
Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence.化生:组织损伤适应性改变及发育异常-癌症序列的前驱病变
Nat Rev Cancer. 2017 Oct;17(10):594-604. doi: 10.1038/nrc.2017.68. Epub 2017 Sep 1.
8
Inflammation and metabolism in tissue repair and regeneration.组织修复和再生中的炎症和代谢。
Science. 2017 Jun 9;356(6342):1026-1030. doi: 10.1126/science.aam7928. Epub 2017 Jun 8.
9
Reprogramming of central carbon metabolism in cancer stem cells.癌症干细胞中中央碳代谢的重编程。
Biochim Biophys Acta Mol Basis Dis. 2017 Jul;1863(7):1728-1738. doi: 10.1016/j.bbadis.2017.05.012. Epub 2017 May 11.
10
Tumor-associated myeloid cells as guiding forces of cancer cell stemness.肿瘤相关髓样细胞作为癌细胞干性的引导力量。
Cancer Immunol Immunother. 2017 Aug;66(8):1025-1036. doi: 10.1007/s00262-017-1997-8. Epub 2017 Apr 11.